<< Kakslc, the scientist, please tell me why so many 18-Oct-08 10:53 pm Phase II's look promising, are touted by the company, spend tens of millions of dollars, huge amounts of time and effort, and then the vast majority of them fail? Explain to me since you are scientist why Phase II's are not designed better, maybe have a few more participants, a few more dollars inorder to prevent so much junk from making to Phase III. I think that is a legitimate question to ask of the biotech world, from investors and cancer patients who hold out so much hope. >> Mero: ?still CEGE you have?
I sold at $4.30 when it ran up so fast. I am thinking about buying some at this low price. They have 128 million cash and GVAX trials still going for other indications. Not sure why an immunity enhancer would be contributed to deaths.